J3245 Injection, tildrakizumab, 1 mg

Billable / valid for submission HCPCS Release 2026Q3

Short description: Inj., tildrakizumab, 1 mg

Version history

Related codes in J32

• J3230 Injection, chlorpromazine hcl, up to 50 mg
• J3240 Injection, thyrotropin alpha, 0.9 mg, provided in 1.1 mg vial
• J3241 Injection, teprotumumab-trbw, 10 mg
• J3243 Injection, tigecycline, 1 mg
• J3244 Injection, tigecycline (accord), not therapeutically equivalent to j3243, 1 mg
• J3246 Injection, tirofiban hcl, 0.25 mg
• J3247 Injection, secukinumab, intravenous, 1 mg
• J3250 Injection, trimethobenzamide hcl, up to 200 mg
• J3260 Injection, tobramycin sulfate, up to 80 mg
• J3262 Injection, tocilizumab, 1 mg
• J3263 Injection, toripalimab-tpzi, 1 mg
• J3265 Injection, torsemide, 10 mg/ml
• J3285 Injection, treprostinil, 1 mg
• J3290 Injection, tranexamic acid, 5 mg
• J3291 Injection, tranexamic acid in sodium chloride, 5 mg
• J3299 Injection, triamcinolone acetonide (xipere), 1 mg

All J32 codes →